Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Thorax”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02639767
What this trial is testing

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT02013063
What this trial is testing

Single Pulmonary Nodule Investigation

Who this might be right for
Malignant Neoplasm of Lung
University Hospital Southampton NHS Foundation Trust 375
Early research (Phase 1)Looking for participantsNCT06764771
What this trial is testing

BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Bristol-Myers Squibb 437
Not applicableEnded earlyNCT00316134
What this trial is testing

Multiple Biomarkers in Undiagnosed Pleural Effusion

Who this might be right for
Pleural EffusionPleural Effusion, Malignant
Fujirebio Diagnostics, Inc. 200
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Testing effectiveness (Phase 2)UnknownNCT01854866
What this trial is testing

Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion

Who this might be right for
Malignant Pleural Effusion,Malignant Ascites
Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Ended earlyNCT01612975
What this trial is testing

The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection

Who this might be right for
Pleural EffusionPleural Effusion Malignant
McMaster University 7
Not applicableLooking for participantsNCT01950572
What this trial is testing

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Who this might be right for
ThymomaStomach NeoplasmsPancreatic Neoplasms+3 more
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)Study completedNCT05278975
What this trial is testing

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Who this might be right for
Malignant Pleural EffusionMalignant Pleural MesotheliomaMesothelioma+3 more
RS Oncology LLC 50
Not applicableUnknownNCT04131231
What this trial is testing

Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion

Who this might be right for
Lung CancerBreast CancerMalignant Pleural Effusion
Peking Union Medical College 248
Not applicableStudy completedNCT03272997
What this trial is testing

The Value of PET-CT in Pleural Effusions

Who this might be right for
Pleural Effusion, Malignant
Naestved Hospital 112
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Large-scale testing (Phase 3)Looking for participantsNCT06915727
What this trial is testing

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Who this might be right for
Childhood Malignant Solid NeoplasmChildhood Malignant Thoracic NeoplasmMalignant Abdominal Neoplasm+3 more
Mayo Clinic 20
Early research (Phase 1)Ended earlyNCT05241873
What this trial is testing

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Who this might be right for
Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more
Blueprint Medicines Corporation 103
Early research (Phase 1)Looking for participantsNCT05969041
What this trial is testing

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

Who this might be right for
Epithelial Tumors, Malignant
Myeloid Therapeutics 48
Early research (Phase 1)Ended earlyNCT03955640
What this trial is testing

Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences

Who this might be right for
Metastatic Malignant Neoplasm in the Chest WallRecurrent Breast Carcinoma
Thomas Jefferson University 3
Testing effectiveness (Phase 2)Study completedNCT00343291
What this trial is testing

Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 121
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Early research (Phase 1)UnknownNCT05826483
What this trial is testing

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Who this might be right for
Malignant Tumor of LungPoor Performance Status
Guangzhou Institute of Respiratory Disease 20
Next Page